Please login to the form below

Not currently logged in
Email:
Password:

CHMP names France's Pierre Demolis vice-chair

He is director of the oncology and haematology division at the ANSM

 Pierre DemolisThe European Medicines Agency (EMA) has appointed France's Dr Pierre Demolis as vice-chair of the Committee for Medicinal Products for Human Use (CHMP).

Dr Demolis is director of the oncology and haematology division at the French Medicines Agency (ANSM) and originally trained as a cardiologist.

In his new role, he will work with chair Dr Tomas Salmonson of Sweden to head the CHMP, which provides recommendations on the use of drugs in the EU.

Dr Demolis' appointment comes after six years serving as a member of the CHMP. He has prior experience at the EMA, including serving as a member of the Scientific Advisory Working Group.

29th October 2013

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics